Total LDH and its isoenzymes in gynecological malignancies and other gynecological conditions. 1988

J Iglesias, and G Borras, and J M Lailla, and A Fortuny, and R Molina, and A Ballesta, and J Sentís
Hospital Clinic, University of Barcelona School of Medicine, Spagna.

Total LDH and its five Isoenzymes have been evaluated in 354 patients from a Gynecological Ward. These patients had uterine fibroids, benign ovarian tumors, tubo-ovarian abscesses (T.O.A.), endometrial cancers, cancers of the cervix and ovarian cancers. 90 patients had no gynecological disease and served as controls. A statistical analysis was performed comparing each group of patients with the control group. A significant elevation in total LDH and Iso-IV and a significant decrease in Iso-I was observed in patients with uterine fibroids. Patients with benign ovarian tumors had a significant elevation of total LDH. Patients with T.O.A., Endometrial cancer, cancer of the cervix and cancer of the ovary had a significant elevations of total LDH and Iso-V and a significant decrease in Iso-I. When the group of patients with endometrial cancer, cancer of the cervix and cancer of the ovary were compared with each other, no differences could be found in total LDH and Isoenzyme values. We conclude that total LDH and Isoenzyme serum levels are not useful clinical indicators for the diagnosis and management of gynecological malignancies and particularly of ovarian cancer.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D007770 L-Lactate Dehydrogenase A tetrameric enzyme that, along with the coenzyme NAD+, catalyzes the interconversion of LACTATE and PYRUVATE. In vertebrates, genes for three different subunits (LDH-A, LDH-B and LDH-C) exist. Lactate Dehydrogenase,Dehydrogenase, L-Lactate,Dehydrogenase, Lactate,L Lactate Dehydrogenase
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D010048 Ovarian Cysts General term for CYSTS and cystic diseases of the OVARY. Corpus Luteum Cyst,Corpus Luteum Cysts,Cyst, Corpus Luteum,Cyst, Ovarian,Cysts, Corpus Luteum,Cysts, Ovarian,Ovarian Cyst
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D010053 Ovary The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE. Ovaries
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Iglesias, and G Borras, and J M Lailla, and A Fortuny, and R Molina, and A Ballesta, and J Sentís
September 2020, Journal of medical biochemistry,
J Iglesias, and G Borras, and J M Lailla, and A Fortuny, and R Molina, and A Ballesta, and J Sentís
January 1976, Nihon rinsho. Japanese journal of clinical medicine,
J Iglesias, and G Borras, and J M Lailla, and A Fortuny, and R Molina, and A Ballesta, and J Sentís
June 1976, Revista clinica espanola,
J Iglesias, and G Borras, and J M Lailla, and A Fortuny, and R Molina, and A Ballesta, and J Sentís
January 1995, European journal of gynaecological oncology,
J Iglesias, and G Borras, and J M Lailla, and A Fortuny, and R Molina, and A Ballesta, and J Sentís
January 1980, Otolaryngologia polska = The Polish otolaryngology,
J Iglesias, and G Borras, and J M Lailla, and A Fortuny, and R Molina, and A Ballesta, and J Sentís
April 1977, The Indian journal of medical research,
J Iglesias, and G Borras, and J M Lailla, and A Fortuny, and R Molina, and A Ballesta, and J Sentís
January 2004, Bulletin du cancer,
J Iglesias, and G Borras, and J M Lailla, and A Fortuny, and R Molina, and A Ballesta, and J Sentís
January 1968, Revista clinica espanola,
J Iglesias, and G Borras, and J M Lailla, and A Fortuny, and R Molina, and A Ballesta, and J Sentís
May 1985, The Journal of the Association of Physicians of India,
J Iglesias, and G Borras, and J M Lailla, and A Fortuny, and R Molina, and A Ballesta, and J Sentís
January 1981, Rinsho byori. The Japanese journal of clinical pathology,
Copied contents to your clipboard!